SAN FRANCISCO, Jan. 29, 2018 /PRNewswire/ -- Invitae
Corporation (NYSE: NVTA), one of the fastest growing genetic
information companies, today announced that it will report its
fourth quarter and year-end 2017 financial results on Monday, February 12, 2018 and will host a
conference call and webcast that day at 4:30
p.m. Eastern / 1:30 p.m.
Pacific to discuss its financial results and recent
developments.
The dial-in numbers for the conference call are (866) 393-4306
for domestic callers and (734) 385-2616 for international callers,
and the reservation number for both is 1395729. Following prepared
remarks, management will respond to questions from investors and
analysts, subject to time limitations. We encourage our
shareholders and those representing them to send in questions to
ir@invitae.com.
The live webcast of the call may be accessed by visiting the
investors section of the company's website at ir.invitae.com. A
replay of the webcast will be available shortly after the
conclusion of the call and will be archived on the company's
website.
About Invitae
Invitae Corporation's (NYSE: NVTA)
mission is to bring comprehensive genetic information into
mainstream medical practice to improve the quality of healthcare
for billions of people. Specializing in genetic diagnostics in
clinical areas across all stages of life, Invitae is aggregating
the world's genetic tests into a single service with better
quality, faster turnaround time, and lower prices. The company
provides a variety of diagnostic tests with clinical utility in
preimplantation and carrier screening for inherited disorders,
miscarriage analysis, pediatric and developmental disorders,
neurological disorders, cardiovascular disorders, metabolic
disorders, and hereditary cancers. For more information, visit our
website at invitae.com.
Contact:
Kate McNeil
ir@invitae.com
347-204-4226
View original content with
multimedia:http://www.prnewswire.com/news-releases/invitae-to-announce-fourth-quarter-and-year-end-2017-financial-results-on-february-12-2018-300589309.html
SOURCE Invitae Corporation